Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 2, 1998, Pages 171-178

  Saillour, F ^a   Bernard, N ^b   Dequae Merchadou, L ^a   Marimoutou, C ^a   Journot, V ^a   Dabis, F ^a,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c INSERM   (France)

Author keywords

Cytomegalovirus infection; HIV infection; Predictive factors; Survival

Indexed keywords

ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPPORTUNISTIC INFECTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0032006308     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199802010-00012     Document Type: Article

References (21)

1. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993;329:1922-6.
2. Réseau National de Santé Publique. Surveillance du SIDA en France. Bull Epidemiol Hebd 1995;(8):31-8.
3. Davis MG, Kenney SC, Kamine J, Pagano JS, Huang ES. Immediate-early gene region of Human cytomegalovirus transactivates the promoter of human immunodeficiency virus. Proc Natl Acad Sci USA 1987;84:642-6.
4. Webster A, Lee CA, Cook DG, Grundy JE, Emery VC, Kernoff PBA. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 1989;2:63-6.
5. Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. The effect of CMV infection on progression of human immunodeficiency virus disease in a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiol Infect 1995;114:361-72.
6. Holland GN. New therapies for cytomegalovirus retinitis [editorial]. N Engl J Med 1995;333:658-9.
7. Marimoutou C, Chene G, Dabis F, Lacoste D, Salamon R for the Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Human immunodeficiency virus and AIDS hospital-based information in Aquitaine, Southwestern France, 1985-1995. Presse Med 1997;26:703-10.
8. Centers for Disease Control. Additional recommendation to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR Morbid Mortal Wkly Rep 1986;35:152-5.
9. Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR Morbid Mortal Wkly Rep 1986;35:334-9.
10. Direction Générale de la Santé. Définition du SIDA avéré (révision 1987). Bull Epidemiol Hebd 1987;(51):201-3.
11. Direction Générale de la Santé. Révision de la définition du SIDA en France. Bull Epidemiol Hebd 1993;(11):47-8.
12. Saillour F, Bernard N, Ragnaud JM, et al. Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. J Infect 1997;35:163-6.
13. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-7.
14. Montforte AA, Mainini F, Vago L, et al. Factors associated with increased risk of acquiring cytomegalovirus disease in AIDS patients. J Infect Dis 1993;168:1071-2.
15. Hoover DR, Peng Y, Saah A, Semba R, Detels RR, Rinaldo CR, Phair JP. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunodepression. Arch Ophthatmol 1996; 114:821-7.
16. Finkelstein DM, Williams PL, Molenberghs G, et al. Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retroviruses 1996;12:38-45.
17. Lee CA, Phillips AN, Elford J, Janossy G, Griffiths P, Kernuff P. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. Br Med J 1991;383:1093-6.
18. Rabkin CS, Hatzakis A, Griffiths PD, Pillay D, Ragni MV, Hilgartner MW, Goedert JJ, the National Cancer Institute Multicenter Hemophilia Cohort Study Group. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. J Infect Dis 1993;168:1260-3.
19. Becherer PR, Smiley ML, Mattews TJ, Weinhold KJ, McMillan CW, White GC. Human immunodeficiency virus-1 disease progression in hemophiliacs. Am J Hematol 1990;34:204-9.
20. Studies of Ocular Complications of AIDS Research Group in collaboration with AIDS clinical trials group. Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and Cytomegalovirus retinitis. J Infect Dis 1995;172:613-21.
21. Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:287-95.